BlackRock’s Asterias Biotherapeutics Warrants AST.WS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q3
– Sell
-2,856
Closed -$1K – 5170
2017
Q2
$1K Hold
2,856
– – ﹤0.01% 5011
2017
Q1
$1K Buy
+2,856
New +$1.05K ﹤0.01% 5004

BlackRock's AST.WS Position: Q3 2017 in Review

BlackRock sold out of Asterias Biotherapeutics Warrants (AST.WS) in Q3 2017, closing a stake of 2,856 shares — an estimated $1K sold.

BlackRock first reported a position in AST.WS in Q1 2017 and held it in 2 quarters. The position peaked at $1K in Q2 2017. 3 funds tracked by Wall St. Rank hold AST.WS as of Q3 2017.

  • BlackRock reported no remaining Asterias Biotherapeutics Warrants position as of Q3 2017 after selling out during the quarter.
  • BlackRock sold 2,856 Asterias Biotherapeutics Warrants shares in Q3 2017, an estimated $1K.
  • BlackRock first reported a position in Asterias Biotherapeutics Warrants in Q1 2017 and held it in 2 quarters.
  • BlackRock's Asterias Biotherapeutics Warrants position peaked at $1K in Q2 2017.
  • 3 funds tracked by Wall St. Rank held Asterias Biotherapeutics Warrants as of Q3 2017.

Based on BlackRock's 13F filing for Q3 2017, filed 14 Nov 2017.